- Report
- January 2025
- 82 Pages
Vietnam
From €3093EUR$3,500USD£2,679GBP
- Report
- October 2024
- 87 Pages
India
From €3093EUR$3,500USD£2,679GBP
- Report
- April 2023
- 111 Pages
Global
From €4197EUR$4,750USD£3,635GBP
- Report
- August 2022
- 120 Pages
Global
From €4197EUR$4,750USD£3,635GBP
- Report
- November 2023
- 320 Pages
Global
From €3932EUR$4,450USD£3,406GBP
- Report
- January 2023
- 154 Pages
From €3049EUR$3,450USD£2,640GBP
- Report
- January 2025
- 75 Pages
Global
From €3500EUR$4,243USD£3,137GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1326EUR$1,500USD£1,148GBP
From €1326EUR$1,500USD£1,148GBP
- Report
- December 2023
- 100 Pages
Africa
From €1767EUR$2,000USD£1,531GBP
- Report
- December 2023
- 180 Pages
Global
From €1105EUR$1,250USD£957GBP
€2209EUR$2,500USD£1,913GBP
- Report
- December 2023
- 80 Pages
United States
From €1326EUR$1,500USD£1,148GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1326EUR$1,500USD£1,148GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1326EUR$1,500USD£1,148GBP
- Report
- December 2023
- 80 Pages
Germany
From €1326EUR$1,500USD£1,148GBP
- Report
- December 2023
- 80 Pages
France
From €1326EUR$1,500USD£1,148GBP
- Report
- December 2023
- 80 Pages
China
From €1326EUR$1,500USD£1,148GBP
- Report
- October 2025
- 95 Pages
Kuwait
From €4286EUR$4,850USD£3,712GBP
- Report
- February 2022
- 90 Pages
Global
From €3200EUR$3,879USD£2,868GBP
- Report
- November 2023
- 90 Pages
Global
From €3500EUR$4,243USD£3,137GBP

Artemisinin is a drug used to treat a variety of infectious diseases, including malaria, schistosomiasis, and filariasis. It is derived from the plant Artemisia annua, and is used in combination with other drugs to increase its effectiveness. Artemisinin is a potent antimalarial drug, and is the most effective treatment for malaria. It is also used to treat other parasitic infections, such as schistosomiasis and filariasis.
Artemisinin is available in a variety of forms, including tablets, capsules, and injections. It is also available in combination with other drugs, such as mefloquine, piperaquine, and doxycycline. The drug is generally well tolerated, with few side effects.
The Artemisinin market is highly competitive, with many companies offering the drug in various forms. Some of the companies in the market include Novartis, Sanofi, GlaxoSmithKline, Cipla, and Ranbaxy. Show Less Read more